Hester Biosciences Limited Share Price & Analysis
Price Chart
Fundamentals
Strengths
- Strong return on equity (ROE 15.9%)
- Efficient capital deployment (ROCE 15.2%)
- Attractively valued vs sector (P/E 38.5x vs industry 54.7x)
Concerns
Peer Comparison
| Company | CMP | Mkt Cap | P/E | P/B | ROE % | ROCE % | D/E |
|---|---|---|---|---|---|---|---|
| SUNPHARMA Sun Pharmaceutical Industries Limited | ₹1,899 | ₹4.6L Cr | 36.1 | 5.46 | 16 | 20.5 | 0.07 |
| DIVISLAB Divi's Laboratories Limited | ₹9,100 | ₹2.4L Cr | 81.1 | 14.42 | 16.5 | 22 | 0.01 |
| TORNTPHARM Torrent Pharmaceuticals Limited | ₹4,857 | ₹1.8L Cr | 82.8 | 19.58 | 27.4 | 15.2 | 0.33 |
| APOLLOHOSP Apollo Hospitals Enterprise Limited | ₹8,650 | ₹1.2L Cr | 59.1 | 13.13 | 21.2 | 17.4 | 0.88 |
| CIPLA Cipla Limited | ₹1,385 | ₹1.1L Cr | 31.3 | 3.25 | 11.6 | 15.5 | 0.01 |
| ZYDUSLIFE Zydus Lifesciences Limited | ₹1,120 | ₹1.1L Cr | 23 | 4.16 | 21.2 | 21.1 | 0.38 |
| LAURUSLABS Laurus Labs Limited | ₹1,840 | ₹99K Cr | 90.9 | 18.74 | 18.3 | 17.8 | 0.46 |
Showing 7 peers in the same sector · Sorted by market cap
Shareholding Pattern
HESTERBIO · as of Mar 2026
| Category | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Promoters | 53.73% | 53.73% | 53.73% | 53.73% | 53.73% | 53.73% |
| FII | 0.43% | 0.43% | 0.52% | 0.61% | 0.59% | 0.87% |
| DII | — | — | — | — | 0.02% | 0.02% |
| Public | 45.83% | 45.84% | 45.74% | 45.66% | 45.65% | 45.38% |
Latest News
All newsHester Biosciences reports Q1 FY26 financial results
*Hester Biosciences reports Q1 FY26 financial results*. Hester Biosciences has announced its financial results for the quarter ended June 30, 2026. The company reported **revenue of ₹123.4 crore** and **net profit of ₹18.7 crore**. Results reflect stable growth in animal healthcare demand. 📊 *STOCKS:* $HESTERBIO | 🏢 *SECTOR:* Pharma | #MEDIUMIMPACT #Earnings
Hester Biosciences releases Q1 FY27 results
*Hester Biosciences releases Q1 FY27 results* reports financial performance for the first quarter of fiscal 2027. The company shared key operational and revenue updates in line with market expectations. No major surprises were noted in the commentary or figures. 📊 *STOCKS:* $HESTERBIO | 🏢 *SECTOR:* Pharma | #MEDIUMIMPACT #Earnings
Hester Biosciences promoters reclassified as public shareholders
*Hester Biosciences promoters reclassified as public shareholders.* Mr. Ravin Gandhi and Ms. Bela Gandhi, previously under Promoter category, are now classified under Public shareholders. This reflects a shift in shareholding pattern but does not imply immediate sale or pledge. Regulatory filings indicate no change in shareholding percentage. 📊 *STOCKS:* $HESTERBIO | 🏢 *SECTOR:* Pharma | #LOWIMPACT #ShareholdingPattern
Hester Biosciences concludes shareholder postal ballot meeting
*Hester Biosciences concludes shareholder postal ballot meeting.* The company has shared voting results from its postal ballot with the exchange. A scrutinizers report and minutes of the meeting have also been submitted. This follows standard corporate procedure for shareholder approvals. 📊 *STOCKS:* $HESTERBIO | 🏢 *SECTOR:* Pharma | #LOWIMPACT #ShareholderMeeting
Hester Biosciences publishes newspaper notice for general meeting
*Hester Biosciences publishes newspaper notice for upcoming general meeting.* The filing is a routine regulatory requirement for convening shareholder meetings. No financial or operational updates were included. **No immediate market-moving details** were disclosed in the notice. 📊 *STOCKS:* $HESTERBIO | 🏢 *SECTOR:* Pharma | #LOWIMPACT #CorporateFiling
Hester Biosciences publishes statutory notice in newspaper
Hester Biosciences has published a statutory notice in a newspaper as part of regulatory compliance. The filing is a routine corporate disclosure with no operational or financial implications. Such notices are standard practice for listed companies. 📊 *STOCKS:* HESTERBIO | 🏢 *SECTOR:* Pharma | #LOWIMPACT #corporate_filing
Hester Biosciences publishes newspaper notice for compliance
*Hester Biosciences publishes newspaper notice for compliance.* This is a routine regulatory filing made in accordance with SEBI guidelines. The notice does not disclose any financial results or strategic developments. Such publications are standard practice for listed companies. 📊 *STOCKS:* HESTERBIO | 🏢 *SECTOR:* Pharma | #LOWIMPACT #Compliance
Hester Biosciences publishes mandatory newspaper notice
*Hester Biosciences publishes mandatory newspaper notice.* This is a routine corporate disclosure as per regulatory requirements. No financial or operational impact is indicated. Such filings are standard practice for listed companies. 📊 *STOCKS:* HESTERBIO | 🏢 *SECTOR:* Pharma | #LOWIMPACT #CorporateFiling
Hester Biosciences sets dividend and meeting record date
*Hester Biosciences sets **14-Jul-2026** as record date for dividend and shareholder meeting.* The company has informed the exchange about the key date for entitlement and participation. This is a routine corporate action with no immediate financial impact. Investors holding shares on the record date will be eligible. 📊 *STOCKS:* HESTERBIO | 🏢 *SECTOR:* Pharma | #LOWIMPACT #Dividend
Hester Biosciences to hold shareholder meeting on July 21, 2026
*Hester Biosciences to hold shareholder meeting on July 21, 2026.* The event is scheduled for **July 21, 2026**, as per a corporate filing. No major announcements expected beyond routine agenda items. This is a standard procedural disclosure. 📊 *STOCKS:* HESTERBIO | 🏢 *SECTOR:* Pharma | #LOWIMPACT #ShareholdersMeeting
About Hester Biosciences Limited
Hester Biosciences Ltd is one of the leading animal health care companies & the second largest poultry vaccine manufacturer in India. Founded by Mr. Rajiv Gandhi in 1987, it has now a presence in over 30 countries & has a key market in India, Nepal & Tanzania. It has partnered with Bill & Melinda Gates Foundation, GALVmed, Golchha Organisation, Novapharma, etc. While operating across four broad verticals of Poultry Vaccines, Poultry Health Products, Animal Vaccines and Animal Health Products, the company provides services like seroprofiling kits and diagnostic labs for poultry flocks, and mastitis control programs for cattle.[1]
HealthcarePharmaceuticals & Biotechnology